Skip to Main Content

Author Details

Michael G Katze
University of Washington
1978
309
94
PMIDPaper TitleJournal TitlePublished Year
31648236Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection.PLoS Pathog2019
31648236Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection.PLoS Pathog2019
28884664Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study.J Gen Virol2017
28951472Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.mBio2017
28542576Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.PLoS Pathog2017
28331091Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.J Virol2017
28884664Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study.J Gen Virol2017
28967519Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.Vaccine2017
29267331Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.PLoS One2017
28099857A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.Cell Rep2017
28331091Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.J Virol2017
28099857A Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection.Cell Rep2017
28967519Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.Vaccine2017
28951472Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.mBio2017
29267331Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.PLoS One2017
28542576Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.PLoS Pathog2017
26867183Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism.Cell Host Microbe2016
27015273FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells.PLoS One2016
26867183Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism.Cell Host Microbe2016
27173929Genomic Signatures of Emerging Viruses: A New Era of Systems Epidemiology.Cell Host Microbe2016
26937040Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques.J Virol2016
27663205The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus.BMC Syst Biol2016
27532264Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection.PLoS One2016
27663205The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus.BMC Syst Biol2016
27173929Genomic Signatures of Emerging Viruses: A New Era of Systems Epidemiology.Cell Host Microbe2016
27532264Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection.PLoS One2016
26937040Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected Macaques.J Virol2016
27015273FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells.PLoS One2016
25392405Tissue-specific transcriptome sequencing analysis expands the non-human primate reference transcriptome resource (NHPRTR).Nucleic Acids Res2015
25933119SIV Infection of Lung Macrophages.PLoS One2015
25589554Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVοG/EBOVgp).Clin Vaccine Immunol2015
25795214Antioxidants Complement the Requirement for Protein Chaperone Function to Maintain β-Cell Function and Glucose Homeostasis.Diabetes2015
25392405Tissue-specific transcriptome sequencing analysis expands the non-human primate reference transcriptome resource (NHPRTR).Nucleic Acids Res2015
25520505Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques.J Virol2015
25600759Gene expression signatures as a therapeutic target for severe H7N9 influenza - what do we know so far?Expert Opin Ther Targets2015
26015500Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.mBio2015
26656717The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice.J Virol2015
26159719Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.Cell Host Microbe2015
26246577Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.J Virol2015
26452100Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross.PLoS Genet2015
26656717The 1918 Influenza Virus PB2 Protein Enhances Virulence through the Disruption of Inflammatory and Wnt-Mediated Signaling in Mice.J Virol2015
26246577Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.J Virol2015
26452100Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross.PLoS Genet2015
26159719Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.Cell Host Microbe2015
26015500Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.mBio2015
25933119SIV Infection of Lung Macrophages.PLoS One2015
25795214Antioxidants Complement the Requirement for Protein Chaperone Function to Maintain β-Cell Function and Glucose Homeostasis.Diabetes2015
25600759Gene expression signatures as a therapeutic target for severe H7N9 influenza - what do we know so far?Expert Opin Ther Targets2015
25520505Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques.J Virol2015
25589554Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVοG/EBOVgp).Clin Vaccine Immunol2015
  • 1 - 50 of 618

Recommended Authors

Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 4
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 12
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 6
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 10
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 1
Roche Pharma Research and Early Development
Career Start Year 2007
Number of shared co-authors 2
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 10
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 18
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 2004
Number of shared co-authors 0
Center for Epigenetics and Metabolism, University of California irvine
Career Start Year 2004
Number of shared co-authors 8
Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 2
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 5
University of California davis
Career Start Year 2002
Number of shared co-authors 4
NYU Grossman School of Medicine
Career Start Year 2001
Number of shared co-authors 15
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 11
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 7
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 7
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 4
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 3
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 14
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 1
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 2
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 9
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 11
University of California los angeles
Career Start Year 1992
Number of shared co-authors 6
University College London
Career Start Year 1992
Number of shared co-authors 2
Institute of Virology, Medical Center - University of Freiburg
Career Start Year 1989
Number of shared co-authors 10
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 3
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 4

Collaborators

Fred Hutchinson Cancer Research Center
Co-authored papers 52
University of Washington
Co-authored papers 28
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 27
Co-authored papers 24
Centers for Disease Control and Prevention.
Co-authored papers 24
Co-authored papers 23
University of North Carolina
Co-authored papers 22
Pacific Northwest National Laboratory
Co-authored papers 21
Influenza Research Institute, University of Wisconsin
Co-authored papers 21
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 19
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers 16
University of Washington
Co-authored papers 15
Pacific Northwest National Laboratory
Co-authored papers 15
University of North Carolina at Chapel Hill
Co-authored papers 15
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 15
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 14
Icahn School of Medicine at Mount Sinai
Co-authored papers 14
Sorbonne University INSERM
Co-authored papers 13
Pacific Northwest National Laboratory
Co-authored papers 11
Clinical Research Division, Fred Hutchinson Cancer Research Center
Co-authored papers 11
University of North Carolina.
Co-authored papers 11
Influenza Research Institute, University of Wisconsin-Madison
Co-authored papers 11
University of Washington, USA Washington National Primate Research Center
Co-authored papers 11
University of Washington
Co-authored papers 10
Pacific Northwest National Laboratory
Co-authored papers 10
Pacific Northwest National Laboratory
Co-authored papers 10
Pacific Northwest National Laboratory
Co-authored papers 9
University of North Carolina at Chapel Hill.
Co-authored papers 9
Pacific Northwest National Laboratory
Co-authored papers 9
University of Chicago, Gwen Knapp Center for Lupus Research.
Co-authored papers 9